Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1860)	8/8/2007 2:55:10 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

ABBI Has been up 14% after it announced that it has received approval from the FDA for its sNDA for Oxytocin Injection, USP, 30 mL.( Sales of Oxytocin in 2006 were around $33M) bigcharts.marketwatch.com ABBI seems to have support at the $20 level. bigcharts.marketwatch.com Bernard

To: Jibacoa who wrote (1860)	1/7/2008 10:26:26 AM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

RIGL Wants to continue its UT without closing its Dec13 UG.<g> bigcharts.marketwatch.com The stock has traded at $25.28 & is still up 7.44% on volume of 373Ks. On Dec13 was when it announced that its R788 demonstrated statistically significant results in treating RA patients in a PII. Groups treated with R788 at 100mg and 150mg po bid, showed higher ACR20, ACR50, ACR70 and DAS28 response rates than the placebo group.(The effect in these dose groups was evident as early as one week after start of therapy.) With some further good news & a close above $30,the stock could easily reach the $40 level.<g> bigcharts.marketwatch.com Bernard